BridgeMD
New treatment option for Metastatic Testicular Cancer
Official title Impact of a Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients
ClinicalTrials.gov ID: NCT05588700
What this study is testing
- What it's testing
- Testicular germ cell tumor (TGCT) is the most common malignancy in men between 15 and 40 years. Although TCGT survivors have a good survival prognosis, they suffer from short- and long-term sequelae such as chronic fatigue, psychological disorders, cardiovascular toxicities and second malignancies.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Men ≥18 years
- With a metastatic germ cell tumor histologically confirmed (seminoma and non-seminoma)
- Who have already undergone an orchidectomy (since the 16th december, this criteria was deleted).
- Having a first line of chemotherapy planned with BEP, EP or VIP
- Having a smartphone (i.e. to connect the activity tracker)
You likely can't join if
- Presence of symptomatic bone and/or brain metastases
- Central nervous system involvement with neurological deficits preventing walking
- History or coexistence of another primary cancer (apart from in situ cancer of any location and/or basal cell skin cancer and/or basal cell skin...
- Contraindication to physical activity (e.g. uncontrolled hypertension, uncontrolled heart disease) uncontrolled heart disease),
- Unable to be followed for medical, social, family, geographical or psychological reasons, during the entire study period,
- Deprived of liberty by judicial or administrative decision, or adults protected by law,
See the full eligibility criteria
- Men ≥18 years
- With a metastatic germ cell tumor histologically confirmed (seminoma and non-seminoma)
- Who have already undergone an orchidectomy (since the 16th december, this criteria was deleted).
- Having a first line of chemotherapy planned with BEP, EP or VIP
- Having a smartphone (i.e. to connect the activity tracker)
- PS \< or = 2
- Whose ability to practice an adapted physical activity (APA) has been certified by a medical certificate issued by the referring oncologist or the investigating physician
- Available and willing to participate in the study for the duration of the intervention and follow-up,
- Able to understand, read and write French,
- Affiliated with a social security scheme,
- Having dated and signed an informed consent.
- Presence of symptomatic bone and/or brain metastases
- Central nervous system involvement with neurological deficits preventing walking
- History or coexistence of another primary cancer (apart from in situ cancer of any location and/or basal cell skin cancer and/or basal cell skin cancer and/or a cancer in complete remission for more than 3 years),
- Contraindication to physical activity (e.g. uncontrolled hypertension, uncontrolled heart disease) uncontrolled heart disease),
- Unable to be followed for medical, social, family, geographical or psychological reasons, during the entire study period,
- Deprived of liberty by judicial or administrative decision, or adults protected by law,
- Concurrent participation in another study in PA.
The study team makes the final eligibility decision.
Where it's taking place
- Angers, France
- Besançon, France
- Bordeaux, France
- Caen, France
- Lille, France
- Lyon, France
- Nancy, France
- Nice, France
- Paris, France
- Rennes, France
- Tours, France
- Villejuif, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Angers, France; Besançon, France; Bordeaux, France; Caen, France; Lille, France; Lyon, France and 6 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.